Hutchin Hill Capital’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-21,300
| Closed | -$131K | – | 809 |
|
2017
Q3 | $131K | Buy |
+21,300
| New | +$131K | 0.01% | 703 |
|
2016
Q4 | – | Sell |
-131,000
| Closed | -$1.23M | – | 865 |
|
2016
Q3 | $1.23M | Buy |
+131,000
| New | +$1.23M | 0.03% | 326 |
|
2015
Q4 | – | Sell |
-75,000
| Closed | -$635K | – | 796 |
|
2015
Q3 | $635K | Sell |
75,000
-176,900
| -70% | -$1.5M | 0.02% | 454 |
|
2015
Q2 | $3.81M | Buy |
251,900
+600
| +0.2% | +$9.07K | 0.1% | 174 |
|
2015
Q1 | $4.02M | Buy |
251,300
+1,300
| +0.5% | +$20.8K | 0.11% | 191 |
|
2014
Q4 | $4.46M | Buy |
250,000
+62,500
| +33% | +$1.11M | 0.16% | 94 |
|
2014
Q3 | $1.88M | Buy |
187,500
+13,412
| +8% | +$135K | 0.07% | 247 |
|
2014
Q2 | $2.72M | Buy |
174,088
+24,088
| +16% | +$376K | 0.12% | 107 |
|
2014
Q1 | $2.78M | Buy |
150,000
+37,500
| +33% | +$696K | 0.14% | 104 |
|
2013
Q4 | $1.9M | Sell |
112,500
-2,500
| -2% | -$42.1K | 0.13% | 152 |
|
2013
Q3 | $1.88M | Sell |
115,000
-60,000
| -34% | -$980K | 0.17% | 107 |
|
2013
Q2 | $1.32M | Buy |
+175,000
| New | +$1.32M | 0.14% | 96 |
|